4//SEC Filing
Melincoff Gwen A 4
Accession 0001209191-22-051009
CIK 0001819411other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:09 PM ET
Size
9.0 KB
Accession
0001209191-22-051009
Insider Transaction Report
Form 4
Melincoff Gwen A
Director
Transactions
- Award
Stock Option (right to buy)
2022-09-20+10,500→ 10,500 totalExercise: $3.50Exp: 2032-09-20→ Common Stock (10,500 underlying)
Footnotes (1)
- [F1]The option vests fully on the day before the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service as a director of the Issuer.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001614890
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 4:09 PM ET
- Size
- 9.0 KB